MAP Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 4, 2011

Attached files

file filename
10-K - FORM 10-K - MAP Pharmaceuticals, Inc.d10k.htm
EX-32.1 - CERTIFICATION OF PEO AND PFO REQUIRED UNDER RULE 13A-14(B) - MAP Pharmaceuticals, Inc.dex321.htm
EX-31.1 - CERTIFICATION OF PEO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) - MAP Pharmaceuticals, Inc.dex311.htm
EX-10.29 - OFFER LETTER - DONALD KELLERMAN - MAP Pharmaceuticals, Inc.dex1029.htm
EX-31.2 - CERTIFICATION OF PFO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) - MAP Pharmaceuticals, Inc.dex312.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-164894 and No. 333-157339) and S-8 (No. 333-165694, No. 333-158253 and No. 333-146656) of MAP Pharmaceuticals, Inc. of our report dated March 4, 2011 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

March 4, 2011

MAP Pharmaceuticals, Inc. Reports